Sector valuations Orion Oyj

Equities

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2026-04-17 EDT			5-day change	1st Jan Change
75.05 ^EUR	+1.90%		+2.67%	+17.91%

04-01	Orion Corporation Appoints Berkeley Vincent as Executive Vice President, Innovative Medicines and A Member of the Orion Executive Team as of 8 April 2026	CI
04-01	Orion appoints new head of Innovative Medicines	FW

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
ORION OYJ	19.49x	6.64x	2.38x	5.06x	14.14x	15.42x	2.52%	12.46B
ELI LILLY AND COMPANY	27.27x	17.01x	0.57x	10.33x	20.7x	22.52x	0.73%	830B
JOHNSON & JOHNSON	25.1x	6.3x	-1.63x	5.77x	15.66x	17.33x	2.28%	564B
ABBVIE INC.	23.45x	139.59x	0.08x	6.27x	12.73x	13.11x	3.32%	369B
ROCHE HOLDING AG	17.18x	6.01x	1.07x	4.23x	10.41x	11.75x	3.13%	328B
ASTRAZENECA PLC	25.85x	5.7x	1.22x	5.33x	15.06x	15.92x	1.62%	318B
MERCK & CO., INC.	28.18x	5.23x	-0.67x	4.9x	15.22x	18.06x	2.84%	294B
NOVARTIS AG	21.14x	6.38x	1104.47x	5.67x	13.72x	15x	2.9%	291B
AMGEN INC.	23.84x	16.98x	5.03x	6.15x	10.83x	13.99x	2.83%	192B
NOVO NORDISK A/S	12.34x	5.22x	-1.48x	4.43x	9.26x	10.9x	4.19%	182B
GILEAD SCIENCES, INC.	18.76x	6.18x	2.29x	5.85x	10.76x	12.64x	2.39%	171B
PFIZER INC.	12.49x	1.78x	0.2x	3.31x	7.96x	9.32x	6.36%	157B
BRISTOL-MYERS SQUIBB COMPANY	12.27x	5.22x	0.29x	3.2x	8.43x	9.24x	4.2%	123B
SANOFI	12x	1.28x	1.78x	2.35x	7.54x	8.31x	5.19%	117B
GSK PLC	13.56x	4.44x	1.13x	2.88x	8.46x	9.53x	3.26%	116B
VERTEX PHARMACEUTICALS INCORPORATED	25.34x	4.99x	1.86x	7.62x	17.17x	17.83x	-.--%	112B
CHUGAI PHARMACEUTICAL CO., LTD.	27.13x	6.05x	1.63x	9.26x	17.41x	18.2x	1.64%	86.92B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	49.99x	1.24x	0.79x	2.82x	10.4x	29.53x	3.58%	55.82B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	40.09x	5.39x	2.1x	9.07x	30.34x	33.11x	0.48%	54.77B
Average	22.92x	13.24x	59.11x	5.50x	13.48x	15.88x	2.81%	230.17B
Weighted average by Cap.	23.01x	19.36x	73.96x	6.22x	14.40x	16.15x	2.5%